Table 3 Association between baseline clinical and laboratory characteristics and mortality of AKI patients lately referred to nephrologist in developing country (n = 103)
Variables | Survivors (n = 40) | Non-survivors (n = 63) | p |
|---|---|---|---|
Gender | |||
Male | 30 (75) | 40 (63.49) | 0.222 |
Female | 10 (25) | 23 (36.51) | |
Age ≥ 60 years | 25 (39.68) | 38 (60.31) | 0.824 |
Oliguria | 28 (38.35) | 45 (61.64) | 0.876 |
Serum creatinine (mg/dL) | |||
Baseline | 3 (3.02) | 4 (3.57) | 0.071 |
Maximum | 4.05 (2.91) | 5 (3.19) | 0.011 |
Blood urea nitrogen (mg/dL) | |||
Baseline | 59.12 (30.31) | 73.99 (36.78) | 0.035 |
Maximum | 87.65 (35.66) | 97.79 (33.96) | 0.157 |
Serum potassium (mg/dL) | |||
Baseline | 4.50 (1.07) | 4.74 (1.34) | 0.337 |
Maximum | 5.10 (1.10) | 5.10 (1.15) | 0.996 |
AKIN | |||
stage I | 18 (45.00) | 17 (27.86) | 0.142 |
stage II | 3 (7.5) | 3 (4.91) | |
stage III | 19 (47.5) | 41 (67.21) | |
KDIGO | |||
stage I | 18 (45.0) | 17 (27.86) | 0.142 |
stage II | 3 (7.5) | 3 (4.91) | |
stage III | 19 (47.5) | 41 (67.21) | |
Nephrologist consultation | |||
≤ 4 days | 28 (70.00) | 28 (44.44) | 0.011 |
> 4 days | 12 (30.00) | 35 (55.55) | |
Hemodialysis | |||
Yes | 30 (75.00) | 33 (52.8) | 0.021 |
No | 10 (25.00) | 30 (47.61) | |